These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28405965)

  • 1. Bayesian regression for group testing data.
    McMahan CS; Tebbs JM; Hanson TE; Bilder CR
    Biometrics; 2017 Dec; 73(4):1443-1452. PubMed ID: 28405965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized additive regression for group testing data.
    Liu Y; McMahan CS; Tebbs JM; Gallagher CM; Bilder CR
    Biostatistics; 2021 Oct; 22(4):873-889. PubMed ID: 32061081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From mixed effects modeling to spike and slab variable selection: A Bayesian regression model for group testing data.
    Joyner CN; McMahan CS; Tebbs JM; Bilder CR
    Biometrics; 2020 Sep; 76(3):913-923. PubMed ID: 31729015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the prevalence of two or more diseases using outcomes from multiplex group testing.
    Warasi MS; Tebbs JM; McMahan CS; Bilder CR
    Biom J; 2023 Oct; 65(7):e2200270. PubMed ID: 37192524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive elastic net for group testing.
    Gregory KB; Wang D; McMahan CS
    Biometrics; 2019 Mar; 75(1):13-23. PubMed ID: 30267535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.
    Warasi MS; Tebbs JM; McMahan CS; Bilder CR
    Stat Med; 2016 Sep; 35(21):3851-64. PubMed ID: 27090057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array testing for multiplex assays.
    Hou P; Tebbs JM; Wang D; McMahan CS; Bilder CR
    Biostatistics; 2020 Jul; 21(3):417-431. PubMed ID: 30371749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression analysis for multiple-disease group testing data.
    Zhang B; Bilder CR; Tebbs JM
    Stat Med; 2013 Dec; 32(28):4954-66. PubMed ID: 23703944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression analysis and variable selection for two-stage multiple-infection group testing data.
    Lin J; Wang D; Zheng Q
    Stat Med; 2019 Oct; 38(23):4519-4533. PubMed ID: 31297869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general regression framework for group testing data, which incorporates pool dilution effects.
    Wang D; McMahan CS; Gallagher CM
    Stat Med; 2015 Nov; 34(27):3606-21. PubMed ID: 26173957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating the dilution effect in group testing regression.
    Mokalled SC; McMahan CS; Tebbs JM; Andrew Brown D; Bilder CR
    Stat Med; 2021 May; 40(11):2540-2555. PubMed ID: 33598950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group testing regression models with dilution submodels.
    Warasi MS; McMahan CS; Tebbs JM; Bilder CR
    Stat Med; 2017 Dec; 36(30):4860-4872. PubMed ID: 28856774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations.
    Bilder CR; Tebbs JM
    Stat Med; 2012 Nov; 31(27):3261-8. PubMed ID: 22415972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informative group testing for multiplex assays.
    Bilder CR; Tebbs JM; McMahan CS
    Biometrics; 2019 Mar; 75(1):278-288. PubMed ID: 30353548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing the pool dilution effect in group testing regression: A Bayesian approach.
    Self S; McMahan C; Mokalled S
    Stat Med; 2022 Oct; 41(23):4682-4696. PubMed ID: 35879887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections.
    Krepel J; Patel J; Sproston A; Hopkins F; Jang D; Mahony J; Chernesky M
    Sex Transm Dis; 1999 Oct; 26(9):504-7. PubMed ID: 10534203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women.
    Kacena KA; Quinn SB; Howell MR; Madico GE; Quinn TC; Gaydos CA
    J Clin Microbiol; 1998 Feb; 36(2):481-5. PubMed ID: 9466763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced sensitivity from pooled urine, pharyngeal and rectal specimens when using a molecular assay for the detection of chlamydia and gonorrhoea near the point of care.
    Badman SG; Bell SFE; Dean JA; Lemoire J; Coffey L; Debattista J; Redmond AM; Williams OD; Gilks CF; Whiley DM
    Sex Health; 2020 Feb; 17(1):15-21. PubMed ID: 31945307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.